16
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Biological and Enzymatic Characterization of Proteases from Crude Venom of the Ant Odontomachus bauri

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hymenoptera venoms constitute an interesting source of natural toxins that may lead to the development of novel therapeutic agents. The present study investigated the enzymatic and biological characteristics of the crude venom of the ant Odontomachus bauri. Its crude venom presents several protein bands, with higher staining for six proteins with gelatinolytic activity (17, 20, 26, 29, 43 and 48 kDa). The crude venom showed high proteolytic activity on azocasein at optimal pH 8.0 and 37 °C. In the presence of protease inhibitors as aprotinin, leupeptin and EDTA, the azocaseinolytic activity was reduced by 45%, 29% and 9%, respectively, suggesting that the enzymes present in the crude venom belong to the three classes of proteases, with the serine proteases in greater intensity. The crude venom degraded the fibrinogen α-chain faster than the β-chain, while the fibrinogen γ-chain remained unchanged. In biological assays, O. bauri venom showed hemolytic and coagulant activity in vitro, and defibrinating activity in vivo. In addition, the venom showed antimicrobial activity against Staphylococcus aureus and Escherichia coli as well as antiparasitic activity on Toxoplasma gondii infection in vitro. In that sense, this study sheds perspectives for pharmacological applications of O. bauri venom enzymes.

          Related collections

          Most cited references47

          • Record: found
          • Abstract: found
          • Article: not found

          Complex cocktails: the evolutionary novelty of venoms.

          Venoms have evolved on numerous occasions throughout the animal kingdom. These 'biochemical weapon systems' typically function to facilitate, or protect the producing animal from, predation. Most venomous animals remain unstudied despite venoms providing model systems for investigating predator-prey interactions, molecular evolution, functional convergence, and novel targets for pharmaceutical discovery. Through advances in 'omic' technologies, venom composition data have recently become available for several venomous lineages, revealing considerable complexity in the processes responsible for generating the genetic and functional diversity observed in many venoms. Here, we review these recent advances and highlight the ecological and evolutionary novelty of venom systems. Copyright © 2012 Elsevier Ltd. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Three Valuable Peptides from Bee and Wasp Venoms for Therapeutic and Biotechnological Use: Melittin, Apamin and Mastoparan

              While knowledge of the composition and mode of action of bee and wasp venoms dates back 50 years, the therapeutic value of these toxins remains relatively unexploded. The properties of these venoms are now being studied with the aim to design and develop new therapeutic drugs. Far from evaluating the extensive number of monographs, journals and books related to bee and wasp venoms and the therapeutic effect of these toxins in numerous diseases, the following review focuses on the three most characterized peptides, namely melittin, apamin, and mastoparan. Here, we update information related to these compounds from the perspective of applied science and discuss their potential therapeutic and biotechnological applications in biomedicine.
                Bookmark

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                Toxins (Basel)
                Toxins (Basel)
                toxins
                Toxins
                MDPI
                2072-6651
                30 November 2015
                December 2015
                : 7
                : 12
                : 5114-5128
                Affiliations
                [1 ]Institute of Biomedical Sciences, Laboratory of Immunoparasitology “Dr. Mario Endsfeldz Camargo”, Federal University of Uberlândia, Av. Pará 1720, Uberlândia 38400-902, Brazil; marianaa_fs@ 123456hotmail.com (M.F.S.); carolinemartinsm@ 123456yahoo.com.br (C.M.M.); vanessa.smiranda@ 123456hotmail.com (V.S.M.); amanda.olicunha@ 123456hotmail.com (A.O.C.); maraisa2003@ 123456yahoo.com.br (M.C.S.); daosilva@ 123456yahoo.com.br (D.A.O.S.); tiagomineo@ 123456icbim.ufu.br (T.W.P.M.)
                [2 ]Institute of Biomedical Sciences, Laboratory of Clinical Bacteriology, Federal University of Uberlândia, Av. Pará 1720, Uberlândia 38400-902, Brazil; kscnaves@ 123456icbim.ufu.br
                [3 ]Institute of Biomedical Sciences, Laboratory of Biophysics, Federal University of Uberlândia, Av. Pará 1720, Uberlândia 38400-902, Brazil; foliveira@ 123456umuarama.ufu.br
                [4 ]National Institute in Science and Technology in Nanobiopharmaceutics (NanoBiofar), Belo Horizonte-MG 31270-901, Brazil
                Author notes
                [* ]Correspondence: fmsantiago@ 123456icbim.ufu.br ; Tel.: +55-34-3225-8666; Fax: +55-34-3218-2333
                Article
                toxins-07-04869
                10.3390/toxins7124869
                4690119
                26633501
                a73397af-6956-4e07-ba7b-a21dd57d388e
                © 2015 by the authors; licensee MDPI, Basel, Switzerland.

                This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 14 August 2015
                : 09 October 2015
                Categories
                Article

                Molecular medicine
                odontomachus bauri,crude venom,proteases,toxoplasma gondii
                Molecular medicine
                odontomachus bauri, crude venom, proteases, toxoplasma gondii

                Comments

                Comment on this article